Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation

ABSTRACT Background: Immunological life-threatening complications frequently occur in post-hematopoietic stem cell transplantation (HSCT), despite matching recipient and donor (R/D) pairs for classical human leukocyte antigens (HLA). Studies have shown that R/D non-HLA disparities within the major histocompatibility complex (MHC) are associated with adverse effects post-HSCT. Methods: We investigated the impact of mismatches of single-nucleotide polymorphisms (SNPs) in C4A/C4B genes, for showing the highest diversity in the MHC gamma block, on 238 patients who underwent HLA 10/10 unrelated donor (URD) HSCT. The endpoints were acute graft-versus-host disease (aGVHD), chronic graft-versus-host disease (cGVHD) and mortality. One hundred and twenty-nine R/D pairs had 23 C4-SNPs typed by PCR-SSP (Gamma-Type™v.1.0), and 109 R/D pairs had these 23 SNPs identified by next-generation sequencing (NGS) using the Illumina platform. Results: The percentage of patients who received HSC from HLA 10/10 donors with 1-7 mismatches was 42.9%. The R/D pairs were considered C4 mismatched when bearing at least one disparity. These mismatches were not found to be risk factors for aGVHD, cGVHD or mortality after unrelated HSCT when SNPs were analyzed together (matched or mm ≥ 1), independently or according to the percentage of incompatibilities (full match for 23 SNPs; 1-3 mm and >3 mm). An exception was the association between 1-3 mismatches at the composite of SNPs C13193/T14952/T19588 with the development of aGVHD (P = 0.012) and with grades III-IV of this disease (P = 0.004). Conclusion: Our data are not consistent with the hypothesis that disparities in C4A/C4B SNPs increase the risks of post-HSCT adverse effects for the endpoints investigated in this study.

Saved in:
Bibliographic Details
Main Authors: Getz,Joselito, Goldenstein,Monica, Bonfim,Carmem, Funke,Vaneuza Moreira, Colturato,Vergílio, Hamerschlak,Nelson, Torres,Margareth, Sayer,David, Boldt,Angelica, Pasquini,Ricardo, Pereira,Noemi Farah
Format: Digital revista
Language:English
Published: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH) 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000300221
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S2531-13792020000300221
record_format ojs
spelling oai:scielo:S2531-137920200003002212020-09-16Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantationGetz,JoselitoGoldenstein,MonicaBonfim,CarmemFunke,Vaneuza MoreiraColturato,VergílioHamerschlak,NelsonTorres,MargarethSayer,DavidBoldt,AngelicaPasquini,RicardoPereira,Noemi Farah SNPs C4A/C4B genes MHC gamma block Unrelated hematopoietic stem cell transplantation GVHD ABSTRACT Background: Immunological life-threatening complications frequently occur in post-hematopoietic stem cell transplantation (HSCT), despite matching recipient and donor (R/D) pairs for classical human leukocyte antigens (HLA). Studies have shown that R/D non-HLA disparities within the major histocompatibility complex (MHC) are associated with adverse effects post-HSCT. Methods: We investigated the impact of mismatches of single-nucleotide polymorphisms (SNPs) in C4A/C4B genes, for showing the highest diversity in the MHC gamma block, on 238 patients who underwent HLA 10/10 unrelated donor (URD) HSCT. The endpoints were acute graft-versus-host disease (aGVHD), chronic graft-versus-host disease (cGVHD) and mortality. One hundred and twenty-nine R/D pairs had 23 C4-SNPs typed by PCR-SSP (Gamma-Type™v.1.0), and 109 R/D pairs had these 23 SNPs identified by next-generation sequencing (NGS) using the Illumina platform. Results: The percentage of patients who received HSC from HLA 10/10 donors with 1-7 mismatches was 42.9%. The R/D pairs were considered C4 mismatched when bearing at least one disparity. These mismatches were not found to be risk factors for aGVHD, cGVHD or mortality after unrelated HSCT when SNPs were analyzed together (matched or mm ≥ 1), independently or according to the percentage of incompatibilities (full match for 23 SNPs; 1-3 mm and >3 mm). An exception was the association between 1-3 mismatches at the composite of SNPs C13193/T14952/T19588 with the development of aGVHD (P = 0.012) and with grades III-IV of this disease (P = 0.004). Conclusion: Our data are not consistent with the hypothesis that disparities in C4A/C4B SNPs increase the risks of post-HSCT adverse effects for the endpoints investigated in this study.info:eu-repo/semantics/openAccessAssociação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH)Hematology, Transfusion and Cell Therapy v.42 n.3 20202020-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000300221en10.1016/j.htct.2019.06.004
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Getz,Joselito
Goldenstein,Monica
Bonfim,Carmem
Funke,Vaneuza Moreira
Colturato,Vergílio
Hamerschlak,Nelson
Torres,Margareth
Sayer,David
Boldt,Angelica
Pasquini,Ricardo
Pereira,Noemi Farah
spellingShingle Getz,Joselito
Goldenstein,Monica
Bonfim,Carmem
Funke,Vaneuza Moreira
Colturato,Vergílio
Hamerschlak,Nelson
Torres,Margareth
Sayer,David
Boldt,Angelica
Pasquini,Ricardo
Pereira,Noemi Farah
Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
author_facet Getz,Joselito
Goldenstein,Monica
Bonfim,Carmem
Funke,Vaneuza Moreira
Colturato,Vergílio
Hamerschlak,Nelson
Torres,Margareth
Sayer,David
Boldt,Angelica
Pasquini,Ricardo
Pereira,Noemi Farah
author_sort Getz,Joselito
title Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
title_short Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
title_full Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
title_fullStr Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
title_full_unstemmed Investigation of MHC gamma block C4A and C4B polymorphisms in unrelated hematopoietic stem cell transplantation
title_sort investigation of mhc gamma block c4a and c4b polymorphisms in unrelated hematopoietic stem cell transplantation
description ABSTRACT Background: Immunological life-threatening complications frequently occur in post-hematopoietic stem cell transplantation (HSCT), despite matching recipient and donor (R/D) pairs for classical human leukocyte antigens (HLA). Studies have shown that R/D non-HLA disparities within the major histocompatibility complex (MHC) are associated with adverse effects post-HSCT. Methods: We investigated the impact of mismatches of single-nucleotide polymorphisms (SNPs) in C4A/C4B genes, for showing the highest diversity in the MHC gamma block, on 238 patients who underwent HLA 10/10 unrelated donor (URD) HSCT. The endpoints were acute graft-versus-host disease (aGVHD), chronic graft-versus-host disease (cGVHD) and mortality. One hundred and twenty-nine R/D pairs had 23 C4-SNPs typed by PCR-SSP (Gamma-Type™v.1.0), and 109 R/D pairs had these 23 SNPs identified by next-generation sequencing (NGS) using the Illumina platform. Results: The percentage of patients who received HSC from HLA 10/10 donors with 1-7 mismatches was 42.9%. The R/D pairs were considered C4 mismatched when bearing at least one disparity. These mismatches were not found to be risk factors for aGVHD, cGVHD or mortality after unrelated HSCT when SNPs were analyzed together (matched or mm ≥ 1), independently or according to the percentage of incompatibilities (full match for 23 SNPs; 1-3 mm and >3 mm). An exception was the association between 1-3 mismatches at the composite of SNPs C13193/T14952/T19588 with the development of aGVHD (P = 0.012) and with grades III-IV of this disease (P = 0.004). Conclusion: Our data are not consistent with the hypothesis that disparities in C4A/C4B SNPs increase the risks of post-HSCT adverse effects for the endpoints investigated in this study.
publisher Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH)
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000300221
work_keys_str_mv AT getzjoselito investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT goldensteinmonica investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT bonfimcarmem investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT funkevaneuzamoreira investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT colturatovergilio investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT hamerschlaknelson investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT torresmargareth investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT sayerdavid investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT boldtangelica investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT pasquiniricardo investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
AT pereiranoemifarah investigationofmhcgammablockc4aandc4bpolymorphismsinunrelatedhematopoieticstemcelltransplantation
_version_ 1756442061224017920